MetaCap

Ardelyx Statistics

NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.99-0.07 (-2.29%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ardelyx by the numbers

Ardelyx has a market capitalization of $751.6 million based on 251.37M shares outstanding. With trailing EPS of $-0.23, Ardelyx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.0% below its 50-day average and 40.1% below its 200-day average.

Average daily trading volume is 4.46M shares, or about $13.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARDX valuation vs. peer median

ARDX compared with the median of 8 peer companies
MetricARDXPeer medianDifference
Market cap$751.60M$766.56M-2%
Forward P/E18.93.5+442%
Avg. volume4.46M1.87M+139%

Peer median across 8 companies: IVA, RIGL, OBX, ORIC, COLL, IRWD, SNDX, VSTM.

Valuation

Market cap
$751.60M
Price / sales (latest FY)
1.85
EPS (TTM)
$-0.23

Price and trading

Previous close
3.06
Open
3.01
Day range
2.95 – 3.08
52-week range
2.80 – 8.40
52-week change
-44.83%
Beta
—
Volume
6.20M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
751.60M
Forward Pe
18.92
Eps
-0.23
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.40
Week52 Low
2.80
Avg Volume
4.46M
Shares Outstanding
251.37M
Ma50
3.22
Ma200
4.99
Earnings Date
Nov 3, 2026
Pct From52w High
-64.40%
Pct From52w Low
6.79%

Related